A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/427 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2591416
Means for the treatment of diabetes which has the high ability to reduce the blood sugar level and is effective in alleviating pancreatic .beta.-cell dysfunction. It is a medicine comprising a combination of an FBPase inhibitor and an insulin resistance reducer which is 5-[4-(6-methoxy-1-methyl-1H- benzoimidazol-2-ylmethoxy)~benzyl]thiazolidine-2,4-dione or a pharmacologically acceptable salt thereof.
La présente invention concerne un moyen de traitement du diabète doté d'une haute capacité à réduire la glycémie et qui est efficace pour réduire le dysfonctionnement des cellules .beta. du pancréas. Le médicament décrit dans l~invention comprend l'association d~un inhibiteur de la FBPase et d~un réducteur de résistance à l~insuline qui est la 5-[4-(6-méthoxy-1-méthyl-1H-benzoimidazol-2-ylméthoxy)benzyl]thiazolidine-2,4-dione ou un sel pharmacologiquement acceptable de celle-ci.
Okuno Akira
Yoshida Taishi
Daiichi Sankyo Company Limited
Marks & Clerk
LandOfFree
Medicinal composition containing fbpase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicinal composition containing fbpase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal composition containing fbpase inhibitor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1404068